Ruggero Beri
Overview
Explore the profile of Ruggero Beri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Argentino G, Olivieri B, Barbieri A, Beri R, Bason C, Friso S, et al.
Biomedicines
. 2024 Feb;
12(2).
PMID: 38397897
Endothelial cell-derived extracellular vesicles (eEVs) are released from endothelial cells, signifying endothelial integrity. Systemic Sclerosis (SSc) is a rare disease causing skin and organ fibrosis with early vascular damage. Iloprost,...
2.
Argentino G, Barbieri A, Beri R, Bason C, Ruzzenente A, Olivieri O, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359285
Endothelin-1 (ET-1) is a vasoactive and profibrotic peptide that plays a pivotal role in diseases such as systemic sclerosis (SSc) and pulmonary arterial hypertension (PAH), by inducing fibrosis and vascular...
3.
Bason C, Barbieri A, Martinelli N, Olivieri B, Argentino G, Bartoloni E, et al.
Front Immunol
. 2021 Oct;
12:753400.
PMID: 34675934
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation mainly affecting the joints leading to cartilage and bone destruction. The definition of seropositive or seronegative RA is...
4.
Tinazzi E, Osti N, Beri R, Argentino G, Veneri D, Dima F, et al.
Autoimmun Rev
. 2020 Jul;
19(9):102616.
PMID: 32682985
Immune Thrombocitopenic Purpura (ITP) is an autoimmune disease characterized by antibody-mediated platelet destruction and variable reduced platelet production. Besides antibody-mediated platelet destruction, new pathogenic mechanisms have been reported to be...
5.
Tinazzi E, Merlin M, Bason C, Beri R, Zampieri R, Lico C, et al.
Front Plant Sci
. 2015 Dec;
6:1080.
PMID: 26648961
Plants are ideal for the production of protein-based nanomaterials because they synthesize and assemble complex multimeric proteins that cannot be expressed efficiently using other platforms. Plant viruses can be thought...
6.
Barbieri A, Dolcino M, Tinazzi E, Rigo A, Argentino G, Patuzzo G, et al.
J Immunol Res
. 2015 Jun;
2015:729654.
PMID: 26090498
The CD30/CD30L signalling system has been implicated in the pathogenesis of several autoimmune and inflammatory conditions. In rheumatoid arthritis (RA), soluble CD30 (sCD30) levels reflect the recruitment of CD30(+) T...
7.
Dolcino M, Ottria A, Barbieri A, Patuzzo G, Tinazzi E, Argentino G, et al.
PLoS One
. 2015 Jun;
10(6):e0128262.
PMID: 26086874
Background: Psoriatic arthritis (PsA) is an inflammatory arthritis whose pathogenesis is poorly understood; it is characterized by bone erosions and new bone formation. The diagnosis of PsA is mainly clinical...
8.
Dolcino M, Patuzzo G, Barbieri A, Tinazzi E, Rizzi M, Beri R, et al.
PLoS One
. 2014 May;
9(5):e97571.
PMID: 24831519
Background: Regular intravenous immunoglobulin treatment is used to replace antibody deficiency in primary immunodeficiency diseases; however the therapeutic effect seems to be related not only to antibody replacement but also...
9.
Tinazzi E, Barbieri A, Rigo A, Patuzzo G, Beri R, Gerli R, et al.
Immunol Lett
. 2014 Jan;
161(2):236-40.
PMID: 24447865
CD30 and CD30 ligand (CD30L) are members of TNF-receptor and TNF superfamilies respectively. CD30(+)T cells are increased in several diseases and interaction between CD30(+) and CD30L(+)T cells leads either to...
10.
Tinazzi E, Dolcino M, Puccetti A, Rigo A, Beri R, Valenti M, et al.
Arthritis Res Ther
. 2010 Jul;
12(4):R131.
PMID: 20609215
Introduction: Circulating endothelial cells are increased in patients affected by systemic sclerosis (SSc) and their number strongly correlates with vascular damage. The effects of iloprost in systemic sclerosis are only...